[11C]Glycylsarcosine: Synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 8, 2005, Pages 2993-3001

  Nabulsi, Nabeel B ^a   Smith, David E ^b   Kilbourn, Michael R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Gly Sar; PepT1 and PepT2 peptide transporters; Renal uptake; 11C Glycylsarcosine

Indexed keywords

GLYCYLSARCOSINE; CARBON; COTRANSPORTER; DIPEPTIDE; HYDROGEN COUPLED OLIGOPEPTIDE TRANSPORTER PEPT2; HYDROGEN-COUPLED OLIGOPEPTIDE TRANSPORTER PEPT2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; EVALUATION; KIDNEY; KIDNEY MEDULLA; KIDNEY PELVIS; KIDNEY TUBULE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; WILD TYPE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; METHODOLOGY; MOUSE MUTANT; PHYSIOLOGY; SCINTISCANNING; STEREOISOMERISM; SYNTHESIS; TIME;

ANIMALS; CARBON RADIOISOTOPES; DIPEPTIDES; KIDNEY; MICE; MICE, KNOCKOUT; MOLECULAR STRUCTURE; POSITRON-EMISSION TOMOGRAPHY; STEREOISOMERISM; SYMPORTERS; TIME FACTORS;

EID: 15244360383     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.02.002     Document Type: Article

References (46)

1. Y.J. Fei, V. Ganapathy, and F.H. Leibach Prog. Nucl. Acid Res. Mol. Biol. 58 1998 239
2. D. Meredith, and C.A. Boyd Cell. Mol. Life Sci. 57 2000 754
3. I. Rubio-Aliaga, and H. Daniel Trends Pharmacol. Sci. 23 2002 434
4. K.I. Inui, S. Masuda, and H. Saito Kidney Int. 58 2000 944
5. D. Herrera-Ruiz, and G.T. Knipp J. Pharm. Sci. 92 2003 691
6. H. Shen, D. Smith, T. Yang, Y. Huang, J. Schnermann, and F. Brosius Am. J. Physiol. Renal. Physiol. 276 1999 F658
7. D.E. Smith, A. Pavlova, U.V. Berger, M.A. Hediger, T. Yang, Y.G. Huang, and J.B. Schnermann Pharm. Res. 15 1998 1244
8. H. Shen, D.E. Smith, R.F. Keep, and F.C. Brosius III Mol. Pharm. 1 2004 248
9. F. Döring, J. Walter, J. Will, M. Föcking, M. Boll, S. Amasheh, W. Clauss, and H. Daniel J. Clin. Invest. 101 1998 2761
10. U.V. Berger, and M.A. Hediger Anat. Embryol. (Berl) 199 1999 439
11. D. Groneberg, F. Doring, M. Nickolaus, H. Daniel, and A. Fischer Neurosci. Lett. 304 2001 181
12. S. Nussberger, and M. Hediger Exper. Nephrol. 3 1995 211
13. M. Palacin, R. Estevez, J. Bertran, and A. Zorzano Physiol. Rev. 78 1998 969
14. I. Rubio-Aliaga, I. Frey, M. Boll, D.A. Groneberg, H.M. Eichinger, R. Balling, and H. Daniel Mol. Cell Biol. 23 2003 3247
15. H. Shen, D.E. Smith, R.F. Keep, J. Xiang, and F.C. Brosius III J. Biol. Chem. 278 2003 4786
16. S.E. Tett, M.J. Kirkpatrick, A.S. Gross, and A. McLachlan J. Clin. Pharmacokinet. 42 14 2003 1193
17. Y.W. Lam, S. Banerji, C. Hatfield, and R.L. Talbert Clin. Pharmacokinet. 32 1997 30
18. H. Daniel, and M. Herget Am. J. Physiol. 273 1997 F1
19. S.A. Adibi Ciba Found. Symp. 50 1977 265
20. S.A. Adibi, and B.A. Krzysik Clin. Sci. Mol. Med. 52 1977 205
21. I.J. Hidalgo, P.L.C.P. Bhatnagar, J. Miller, G. Cucullino, and P.L. Smith Pharm. Res. 12 1995 317
22. T. Mizuma, S. Masubuchi, and S. Awazu J. Pharm. Pharmacol. 50 1998 167
23. T. Terada, K. Sawada, M. Saito, Y. Hashimoto, and K.-I. Inui Eur. J. Physiol. 440 2000 679
24. J.G. Wagner Fundamentals of Clinical Pharmacokinetics 1975 Drug Intelligence Publications Hamilton, IL
25. H. Daniel, E.L. Morse, and S.A. Adibi J. Biol. Chem. 267 1992 9565
26. C. Goolcharran, and R. Borchardt J. Pharm. Sci. 87 1998 283
27. J. Purdie, and N.L. Benoiton J. Chem. Soc., Perkins Trans. 2 1973 1845
28. S. Capasso, and L. Mazzarella Peptides 19 1998 389
29. B.D. Sykes, E.B. Robertson, H.B. Dunford, and D. Konasewich Biochemistry 5 1966 697
30. The MMFF94 is one of the most reliable force fields for protein modeling in terms of predicting conformational energy differences and barrier height about single-bond torsions. See Refs. 31-33
31. I.N. Levine Quantum Chemistry 5th ed. 1999 Prentice Hall Upper Saddler River, NJ p 701
32. T.A. Halgren, and R.B. Nachbar J. Comput. Chem. 17 1996 587
33. T.A. Halgren J. Comput. Chem. 20 1999 720
34. Calculations performed with the computational chemistry software package Spartan 02, release 116; Wavefunction, Inc.: Irvine, California
35. J.B. Li J. Anal. Purif. 2 1987 72
36. B.H. Chase, and A.M. Downes J. Chem. Soc. 1953 3874
37. P. Levene, L. Bass, and R. Steiger J. Biol. Chem. 81 1929 697
38. W. Foye, and D. Kay J. Am. Pharm. Assoc. 49 1960 705
39. T. Harris, T. Reilly, and J. DelPrincipe J. Heterocycl. Chem. 18 1981 423
40. J.G. Samaritoni, D.A. Demeter, J.M. Gifford, G.B. Watson, M.S. Kempe, and T.J. Bruce J. Agric. Food. Chem. 51 2003 3035
41. D. Jewett Appl. Radiat. Isot. 43 1992 1383
42. 11C]methyl triflate was bubbled at ambient temperature
43. Flow rate is 1.0 mL/min with Showa Denko polymethacrylate RSpak Shodex DE-613 (6.0 × 150 mm) HPLC column eluting at 5.1 min
44. Sometimes it was necessary to reflux for longer than 8 min or use of 4 N NaOH to achieve total conversion when the solution volume remained over 1.5 mL
45. Q. Bai Ki, C.H. Holdsworth, E. Asma, Y.C. Tai, A. Charziioannou, and R.M. Leahy Phys. Med. Biol. 47 2002 2773
46. J. Qi, R.M. Leahy, S.R. Cherry, A. Charziioannou, and T.H. Furquhar Phys. Med. Biol. 43 1998 1001